G. Chai, R. Zeng, C. Fu, S. Ma
FULL PAPER
+ five protons in cyclohexyl group), 0.87 (t, J = 7.1 Hz, 3 H, CH3),
0.09 [s, 9 H, Si(CH3)3] ppm. 13C NMR (CDCl3, 75 MHz): δ =
173.4, 139.6, 124.9, 51.0, 43.6, 41.4, 34.6, 33.6, 32.1, 28.4, 27.10,
(t, J = 11.6 Hz, 1 H, one proton in c-hexyl group), 1.89 (d, J =
12.6 Hz, 1 H, one proton in c-hexyl group), 1.78–1.60 (m, 4 H, 4
protons in c-hexyl group), 1.36–0.93 [m, 14 H, C(CH3)3 + five pro-
tons in c-hexyl group], 0.14 [s, 9 H, Si(CH3)3] ppm. 13C NMR
27.06, 26.3, 22.4, 14.0, –1.2 ppm. IR (neat): ν = 2926, 2852, 1724,
˜
1645, 1449, 1432, 1321, 1250, 1190, 1152, 1131, 1113 cm–1. MS (CDCl3, 75 MHz): δ = 173.4, 140.0, 135.4, 51.0, 42.8, 42.5, 36.1,
(EI): m/z (%) = 310 (24.15) [M]+, 73 (100). HRMS: calcd. for
34.8, 31.84, 31.76, 27.4, 27.3, 26.4, –0.9 ppm. IR (neat): ν = 2927,
˜
C18H34O2Si [M]+ 310.2328; found 310.2329.
2851, 1727, 1635, 1448, 1432, 1364, 1301, 1251, 1214, 1164, 1144,
1125 cm–1. MS (EI): m/z (%) = 310 (50.80) [M]+, 191 (100). HRMS:
calcd. for C18H34O2Si [M]+ 310.2328; found 310.2322.
9. Methyl (3Z)-3-Cyclohexyl-2-(trimethylsilyl)tridec-3-enoate [(Z)-
2i]: Use of the Typical Procedure with Fe(acac)3 (4.3 mg,
0.012 mmol, 2 mol-%), 1b (177.2 mg, 0.6 mmol), and c-C6H11MgCl
(0.33 mL, 2 m solution in Et2O, 0.66 mmol, 1.1 equiv.) in Et2O
(5 mL) afforded (Z)-2i (215.7 mg, 95%) as a liquid. 1H NMR
13. Methyl (3Z)-3-tert-Butyl-2-(trimethylsilyl)oct-3-enoate [(Z)-2m]:
Use of the Typical Procedure with Fe(acac)3 (4.3 mg, 0.012 mmol,
2 mol-%), 1a (136.0 mg, 0.6 mmol), and tBuMgCl (1.1 mL, 1.7 m
(300 MHz, CDCl3): δ = 5.20 (t, J = 6.8 Hz, 1 H, HC=C), 3.62 (s, solution in Et2O, 1.87 mmol, 3 equiv.) in Et2O (5 mL) afforded (Z)-
1
3 H, OCH3), 3.17 (s, 1 H, CH), 2.09–1.97 (m, 1 H, CH), 1.92 (q,
J = 7.0 Hz, 2 H, CH2), 1.78–1.60 (m, 5 H, five protons in cyclo-
hexyl group), 1.38–0.96 (m, 19 H, 7ϫ CH2 + five protons in cyclo-
hexyl group), 0.87 (t, J = 6.5 Hz, 3 H, CH3), 0.10 [s, 9 H, Si(CH3)
3] ppm. 13C NMR (CDCl3, 75 MHz): δ = 173.4, 139.6, 125.0, 51.1,
2m (153.2 mg, 90%) as a liquid. H NMR (300 MHz, CDCl3): δ =
5.40 (t, J = 6.9 Hz, 1 H, HC=C), 3.63 (s, 3 H, OCH3), 3.13 (s, 1
H, CH), 2.15–1.99 (m, 1 H, one proton in CH2), 1.84–1.69 (m, 1
H, one proton in CH2), 1.52–1.26 (m, 4 H, 2ϫ CH2), 0.98 [s, 9 H,
C(CH3)3], 0.90 (t, J = 7.1 Hz, 3 H, CH3), 0.14 [s, 9 H, Si(CH3)
43.6, 41.5, 34.7, 33.7, 31.9, 29.9, 29.6, 29.4, 29.3, 28.7, 27.12, 27.09, 3] ppm. 13C NMR (CDCl3, 75 MHz): δ = 173.3, 140.3, 125.5, 51.1,
26.4, 22.7, 14.1, –1.1 ppm. IR (neat): ν = 2925, 2853, 1725, 1645, 38.4, 37.2, 32.1, 30.8, 28.9, 22.8, 14.2, 0.2 ppm. IR (neat): ν = 2955,
˜
˜
1449, 1432, 1320, 1249, 1192, 1149, 1131 cm–1. MS (EI): m/z (%) 2872, 1739, 1704, 1479, 1465, 1432, 1353, 1328, 1251, 1158,
= 380 (18.29) [M]+, 73 (100). HRMS: calcd. for C23H44O2Si [M]+
380.3111; found 380.3114.
1142 cm–1. MS (EI): m/z (%) = 284 (15.07) [M]+, 137 (100). HRMS:
calcd. for C16H32O2Si [M]+ 284.2172; found 284.2165.
10. Methyl
(3Z)-3,4-Dicyclohexyl-2-(trimethylsilyl)but-3-enoate 14. Methyl (3Z)-3-Phenyl-2-(trimethylsilyl)oct-3-enoate [(Z)-2n]:
[(Z)-2j]: Use of the Typical Procedure with Fe(acac)3 (4.1 mg,
0.012 mmol, 2 mol-%), 1c (152.8 mg, 0.6 mmol), and c-C6H11MgCl
(0.33 mL, 2 m solution in Et2O, 0.66 mmol, 1.1 equiv.) in Et2O
Use of the Typical Procedure with Fe(acac)3 (4.1 mg, 0.012 mmol,
2 mol-%), 1a (135.6 mg, 0.6 mmol), and PhMgBr (0.22 mL, 3 m
solution in Et2O, 0.66 mmol, 1.1 equiv.) in Et2O (5 mL) afforded
1
1
(5 mL) afforded (Z)-2j (167.8 mg, 82%, Z/E 98:2) as a liquid. H
(Z)-2n (159.1 mg, 87%) as a liquid. H NMR (300 MHz, CDCl3):
NMR (300 MHz, CDCl3): δ = 5.01 (d, J = 9.6 Hz, 1 H, HC=C),
δ = 7.53–7.34 (m, 5 H, Ar-H), 5.88 (t, J = 7.2 Hz, 1 H, HC=C),
3.61 (s, 3 H, OCH3), 3.16 (s, 1 H, CH), 2.06–1.92 (m, 2 H, 2ϫ 3.89 (s, 3 H, OCH3), 3.70 (s, 1 H, CH), 2.44–2.20 (m, 2 H, CH2),
CH), 1.78–1.50 (m, 10 H, 10 protons in cyclohexyl groups), 1.34–
0.90 (m, 10 H, 10 protons in cyclohexyl groups), 0.10 [s, 9 H,
Si(CH3)3] ppm. 13C NMR (CDCl3, 75 MHz): δ = 173.6, 137.9,
1.70–1.50 (m, 4 H, 2ϫ CH2), 1.11 (t, J = 7.1 Hz, 3 H, CH3), 0.23
[s, 9 H, Si(CH3)3] ppm. 13C NMR (CDCl3, 75 MHz): δ = 173.6,
145.0, 135.5, 132.8, 127.8, 127.4, 126.5, 51.4, 41.3, 31.7, 29.6, 22.5,
130.9, 51.1, 43.0, 41.8, 37.0, 35.0, 33.9, 33.4, 33.3, 27.2, 27.1, 26.4, 14.0, –0.6 ppm. IR (neat): ν = 3056, 3020, 2955, 2929, 2872, 1728,
˜
26.1, 26.04, 25.95 ppm. IR (neat): ν = 2925, 2851, 1725, 1449, 1432, 1493, 1443, 1433, 1250, 1190, 1154 cm–1. MS (EI): m/z (%) = 304
˜
1249, 1192, 1155, 1119 cm–1. MS (EI): m/z (%) = 336 (19.99)
[M]+, 73 (100). HRMS: calcd. for C20H36O2Si [M]+ 336.2485;
found 336.2491.
(15.20) [M]+, 157 (100). HRMS: calcd. for C18H28O2Si [M]+
304.1859; found 304.1850.
15. Methyl (3Z)-3-Phenyl-2-(trimethylsilyl)tridec-3-enoate [(Z)-2o]:
Use of the Typical Procedure with Fe(acac)3 (4.2 mg, 0.012 mmol,
2 mol-%), 1b (177.0 mg, 0.6 mmol), and PhMgBr (0.22 mL, 3 m
solution in Et2O, 0.66 mmol, 1.1 equiv.) in Et2O (5 mL) afforded
11. Methyl (3Z)-3-Cyclohexyl-2-(trimethylsilyl)tetradeca-3,13-dien-
oate [(Z)-2k]: Use of the Typical Procedure with Fe(acac)3 (4.2 mg,
0.012 mmol, 2 mol-%), 1d (184.0 mg, 0.6 mmol), and c-C6H11MgCl
(0.33 mL, 2 m solution in Et2O, 0.66 mmol, 1.1 equiv.) in Et2O
(5 mL) afforded (Z)-2k (218.6 mg, 93%) as a liquid. 1H NMR
(300 MHz, CDCl3): δ = 5.87–5.71 (m, 1 H, HC=C), 5.20 (t, J =
7.1 Hz, 1 H, HC=C), 5.03–4.87 (m, 2 H, H2C=C), 3.61 (s, 3 H,
OCH3), 3.17 (s, 1 H, CH), 2.02 (q, J = 7.0 Hz, 3 H, CH2 + CH),
1.92 (q, J = 6.9 Hz, 2 H, CH2), 1.80–1.58 (m, 5 H, five protons in
cyclohexyl group), 1.43–0.94 (m, 17 H, 6ϫ CH2 + five protons in
1
(Z)-2o (204.1 mg, 91%) as a liquid. H NMR (300 MHz, CDCl3):
δ = 7.54–7.30 (m, 5 H, Ar-H), 5.88 (t, J = 7.4 Hz, 1 H, HC=C),
3.89 (s, 3 H, OCH3), 3.69 (s, 1 H, CH), 2.43–2.20 (m, 2 H, CH2),
1.70–1.35 (m, 14 H, 7ϫ CH2), 1.07 (t, J = 6.5 Hz, 3 H, CH3), 0.23
[s, 9 H, Si(CH3)3] ppm. 13C NMR (CDCl3, 75 MHz): δ = 173.6,
145.0, 135.5, 132.9, 127.8, 127.4, 126.5, 51.4, 41.3, 31.9, 29.9, 29.56,
29.52, 29.50, 29.3, 22.7, 14.1, –0.6 ppm. IR (neat): ν = 2925, 2854,
˜
cyclohexyl group), 0.10 [s, 9 H, Si(CH3)3] ppm. 13C NMR (CDCl3, 1728, 1492, 1464, 1432, 1250, 1153 cm–1. MS (EI): m/z (%) = 374
75 MHz): δ = 173.4, 139.6, 139.1, 124.9, 114.1, 51.0, 43.6, 41.5,
34.7, 33.8, 33.6, 29.8, 29.5, 29.41, 29.36, 29.1, 28.9, 28.7, 27.10,
(39.96) [M]+, 157 (100). HRMS: calcd. for C23H38O2Si [M]+
374.2641; found 374.2646.
27.08, 26.3, –1.1 ppm. IR (neat): ν = 2925, 2852, 1724, 1641, 1448,
˜
16. Methyl (3Z)-4-Cyclohexyl-3-phenyl-2-(trimethylsilyl)but-3-eno-
ate [(Z)-2p]: Use of the Typical Procedure with Fe(acac)3 (4.2 mg,
0.012 mmol, 2 mol-%), 1c (151.0 mg, 0.6 mmol), and PhMgBr
(0.22 mL, 3 m solution in Et2O, 0.66 mmol, 1.1 equiv.) in Et2O
1432, 1320, 1249, 1192, 1151, 1129 cm–1. MS (EI): m/z (%) = 392
(3.13) [M]+, 163 (100). HRMS: calcd. for C24H44O2Si [M]+
392.3111; found 392.3117.
12. Methyl (3Z)-3-Cyclohexyl-5,5-dimethyl-2-(trimethylsilyl)hex-3- (5 mL) afforded (Z)-2p (167.3 mg, 85%) as a liquid. 1H NMR
enoate [(Z)-2l]: Use of the Typical Procedure with Fe(acac)3
(300 MHz, CDCl3): δ = 7.54–7.48 (m, 2 H, Ar-H), 7.47–7.34 (m, 3
(4.1 mg, 0.012 mmol, 2 mol-%), 1f (135.4 mg, 0.6 mmol), and c- H, Ar-H), 5.70 (d, J = 9.6 Hz, 1 H, HC=C), 3.90 (s, 3 H, OCH3),
C6H11MgCl (0.36 mL, 2 m solution in Et2O, 0.72 mmol, 1.2 equiv.)
in Et2O (5 mL) afforded (Z)-2l (146.4 mg, 79%, eluent: petroleum
3.69 (s, 1 H, CH), 2.47–2.31 (m, 1 H, CH), 2.00–1.80 (m, 5 H, five
protons in cyclohexyl group), 1.60–1.22 (m, 5 H, five protons in
ether/CH2Cl2 7:1) as a liquid. 1H NMR (300 MHz, CDCl3): δ = cyclohexyl group), 0.22 [s, 9 H, Si(CH3)3] ppm. 13C NMR (CDCl3,
5.22 (s, 1 H, HC=C), 3.63 (s, 3 H, OCH3), 3.60 (s, 1 H, CH), 2.03
75 MHz): δ = 173.8, 144.9, 138.3, 133.7, 127.8, 127.6, 126.5, 51.5,
152
www.eurjoc.org
© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2013, 148–154